TCF2 Attenuates FFA-induced Damage in Islet β-cells by Regulating Production of Insulin and ROS

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2014 Aug 1

PMID 25079440

Citations 9

Authors

Xiaojuan Quan

Lin Zhang

Yingna Li

Chunlian Liang

Affiliations

Soon will be listed here.

Abstract

Free fatty acids (FFAs) are cytotoxic to pancreatic islet β-cells and play a crucial role in the diabetes disease process. A recent study revealed a down-regulation of transcription factor 2 (TCF2) levels during FFA-mediated cytotoxicity in pancreatic β-cells. However, its function during this process and the underlying mechanism remains unclear. In this study, treatment with palmitic acid (PA) at high levels (400 and 800 μM) decreased β-cell viability and TCF2 protein expression, along with the glucose-stimulated insulin secretion (GSIS). Western and RT-PCR analysis confirmed the positive regulatory effect of TCF2 on GSIS through promotion of the key regulators pancreatic duodenal homeobox-1 (PDX1) and glucose transporter 2 (GLUT2) in β-cells. In addition, both PI3K/AKT and MEK/ERK showed decreased expression in PA (800 μM)-treated β-cells. Overexpression of TCF2 could effectively restore the inhibitory effect of PA on the activation of PI3K/AKT and MEK/ERK as well as β-cell viability, simultaneously, inhibited PA-induced reactive oxygen species (ROS) generation. After blocking the PI3K/AKT and MAPK/ERK signals with their specific inhibitor, the effect of overexpressed TCF2 on β-cell viability and ROS production was obviously attenuated. Furthermore, a protective effect of TCF2 on GSIS by positive modulation of JNK-PDX1/GLUT2 signaling was also confirmed. Accordingly, our study has confirmed that TCF2 positively modulates insulin secretion and further inhibits ROS generation via the PI3K/AKT and MEK/ERK signaling pathways. Our work may provide a new therapeutic target to achieve prevention and treatment of diabetes.

Citing Articles

All-trans retinoic acid impairs glucose-stimulated insulin secretion by activating the RXR/SREBP-1c/UCP2 pathway.

Yang H, Liu M, Sheng Y, Zhu L, Jin M, Jiang T Acta Pharmacol Sin. 2021; 43(6):1441-1452.

PMID: 34417575 PMC: 9160277. DOI: 10.1038/s41401-021-00740-2.

Molecular Mechanisms of Apoptosis Induction and Its Regulation by Fatty Acids in Pancreatic β-Cells.

Sramek J, Nemcova-Furstova V, Kovar J Int J Mol Sci. 2021; 22(8).

PMID: 33924206 PMC: 8074590. DOI: 10.3390/ijms22084285.

Gestational bisphenol A exposure induces fatty liver development in male offspring mice through the inhibition of HNF1b and upregulation of PPARγ.

Long Z, Fan J, Wu G, Liu X, Wu H, Liu J Cell Biol Toxicol. 2020; 37(1):65-84.

PMID: 32623698 PMC: 7851022. DOI: 10.1007/s10565-020-09535-3.

Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance.

Schultheis J, Beckmann D, Mulac D, Muller L, Esselen M, Dufer M Oxid Med Cell Longev. 2019; 2019:7518510.

PMID: 31827698 PMC: 6885177. DOI: 10.1155/2019/7518510.

Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.

Liang C, Hao F, Yao X, Qiu Y, Liu L, Wang S Int J Biol Sci. 2019; 15(7):1472-1487.

PMID: 31337977 PMC: 6643136. DOI: 10.7150/ijbs.33817.

References

Zhang X, Qiao H, Zhao Y, Wang X, Sun H, Liu A . Association of single nucleotide polymorphisms in TCF2 with type 2 diabetes susceptibility in a Han Chinese population. PLoS One. 2013; 7(12):e52938. PMC: 3534126. DOI: 10.1371/journal.pone.0052938. View

Pedersen K, Chhabra K, Nguyen V, Xia H, Lazartigues E . The transcription factor HNF1α induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs. Biochim Biophys Acta. 2013; 1829(11):1225-35. PMC: 3838857. DOI: 10.1016/j.bbagrm.2013.09.007. View

Seino S, Shibasaki T, Minami K . Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest. 2011; 121(6):2118-25. PMC: 3104758. DOI: 10.1172/JCI45680. View

de Souza L, Barreto F, da Silva E, Andrades M, Guimaraes E, Behr G . Regulation of LPS stimulated ROS production in peritoneal macrophages from alloxan-induced diabetic rats: involvement of high glucose and PPARgamma. Life Sci. 2007; 81(2):153-9. DOI: 10.1016/j.lfs.2007.04.035. View

Samuel V, Shulman G . Mechanisms for insulin resistance: common threads and missing links. Cell. 2012; 148(5):852-71. PMC: 3294420. DOI: 10.1016/j.cell.2012.02.017. View

Eckel R, Kahn S, Ferrannini E, Goldfine A, Nathan D, Schwartz M . Obesity and type 2 diabetes: what can be unified and what needs to be individualized?. J Clin Endocrinol Metab. 2011; 96(6):1654-63. PMC: 3206399. DOI: 10.1210/jc.2011-0585. View

Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A . Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010; 161(4):799-814. PMC: 2992896. DOI: 10.1111/j.1476-5381.2010.00910.x. View

Chen Y, Huang C, Tsai K, Yang R, Yen C, Yang C . The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Diabetes. 2006; 55(6):1614-24. DOI: 10.2337/db06-0029. View

Pipeleers D, Ling Z . Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev. 1992; 8(3):209-27. DOI: 10.1002/dmr.5610080303. View

10.

Yuan H, Zhang X, Huang X, Lu Y, Tang W, Man Y . NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways. PLoS One. 2011; 5(12):e15726. PMC: 3012098. DOI: 10.1371/journal.pone.0015726. View

11.

Newsholme P, Haber E, Hirabara S, Rebelato E, Procopio J, Morgan D . Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol. 2007; 583(Pt 1):9-24. PMC: 2277225. DOI: 10.1113/jphysiol.2007.135871. View

12.

Kharroubi I, Ladriere L, Cardozo A, Dogusan Z, Cnop M, Eizirik D . Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology. 2004; 145(11):5087-96. DOI: 10.1210/en.2004-0478. View

13.

Ozasa R, Okada T, Nadanaka S, Nagamine T, Zyryanova A, Harding H . The antipsychotic olanzapine induces apoptosis in insulin-secreting pancreatic β cells by blocking PERK-mediated translational attenuation. Cell Struct Funct. 2013; 38(2):183-95. DOI: 10.1247/csf.13012. View

14.

Boden G, Shulman G . Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002; 32 Suppl 3:14-23. DOI: 10.1046/j.1365-2362.32.s3.3.x. View

15.

Holland A, Garcia S, Naselli G, MacDonald R, Harrison L . The Parahox gene Pdx1 is required to maintain positional identity in the adult foregut. Int J Dev Biol. 2013; 57(5):391-8. DOI: 10.1387/ijdb.120048ah. View

16.

Ayvaz G, Balos Toruner F, Karakoc A, Yetkin I, Cakir N, Arslan M . Acute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of islets. Diabetes Metab. 2003; 28(6 Pt 2):3S7-12; discussion 3S108-12. View

17.

Baldwin A, Green C, Olson L, Moxley M, Corbett J . A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death. Am J Physiol Endocrinol Metab. 2012; 302(11):E1390-8. PMC: 3378068. DOI: 10.1152/ajpendo.00519.2011. View

18.

Buchanan T . Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther. 2003; 25 Suppl B:B32-46. DOI: 10.1016/s0149-2918(03)80241-2. View

19.

Tarantino G, Caputi A . JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol. 2011; 17(33):3785-94. PMC: 3181439. DOI: 10.3748/wjg.v17.i33.3785. View

20.

Zhang Y, Moerkens M, Ramaiahgari S, de Bont H, Price L, Meerman J . Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res. 2011; 13(3):R52. PMC: 3218939. DOI: 10.1186/bcr2883. View